← Browse by Condition
Medical Condition
atopic dermatitis
Total Trials
25
Recruiting Now
25
Trial Phases
Phase 4, Phase 1, Phase 2
NCT07467564
Recruiting
The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment
184 pts
Location
United Arab Emirates
Sponsor
Sanofi
NCT06004986 Phase 4
Recruiting
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
Enrollment
216 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
NCT05938478
Recruiting
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
Enrollment
900 pts
Location
United States
Sponsor
University of California, San ...
NCT06564389 Phase 1
Recruiting
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Enrollment
119 pts
Location
United States
Sponsor
Pfizer
NCT06524635 Phase 2
Recruiting
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Enrollment
60 pts
Location
United States
Sponsor
AbbVie
NCT04864886
Recruiting
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Enrollment
300 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT04334031
Recruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
Enrollment
2,200 pts
Location
France
Sponsor
University Hospital, Lille
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canad...
Sponsor
Inmagene LLC
NCT06244212
Recruiting
Topical Treatment for Atopic Dermatitis
Enrollment
30 pts
Location
United States
Sponsor
Wake Forest University Health ...
NCT06947980 Phase 2
Recruiting
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment
200 pts
Location
China
Sponsor
Keymed Biosciences Co.Ltd
NCT06055361 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Enrollment
45 pts
Location
United States
Sponsor
Brexogen Inc.
NCT07006792 Phase 4
Recruiting
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
Enrollment
200 pts
Location
United States, Argen...
Sponsor
Eli Lilly and Company
NCT06937788
Recruiting
Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
Enrollment
240 pts
Location
Germany
Sponsor
Technische Universität Dresden
NCT07193589 Phase 2
Recruiting
A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis
Enrollment
111 pts
Location
China
Sponsor
Chengdu Zenitar Biomedical Tec...
NCT07399067 Phase 2
Recruiting
A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
Enrollment
120 pts
Location
China
Sponsor
Innovent Biologics (Suzhou) Co...
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Enrollment
200 pts
Location
United States, Canad...
Sponsor
AbbVie
NCT07250997
Recruiting
PALLAS Laser for Skin Diseases
Enrollment
50 pts
Location
Hungary
Sponsor
Szeged University
NCT07297602 Phase 2
Recruiting
Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study
Enrollment
36 pts
Location
Egypt
Sponsor
Nora Mohamed Abdelrazik
NCT06362629
Recruiting
AI App for Management of Atopic Dermatitis
Enrollment
232 pts
Location
China
Sponsor
West China Hospital
NCT05790330
Recruiting
Mind and Skin - the Neurocutaneous Axis in Atopic Eczema
Enrollment
90 pts
Location
United Kingdom
Sponsor
King's College London
NCT05858619 Phase 4
Recruiting
Molecular Signatures of Cutaneous Dupilumab Response
Enrollment
15 pts
Location
United States
Sponsor
University of California, San ...
NCT06448689
Recruiting
Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis
Enrollment
90 pts
Location
France
Sponsor
ActiGraph L.L.C
NCT07015762 Phase 1
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
Enrollment
9 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canad...
Sponsor
Organon and Co
NCT05099315
Recruiting
Microbiome in Atopic Dermatitis Under Systemic Therapy
Enrollment
600 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...